tiprankstipranks
Trending News
More News >
Vir Biotechnology, Inc. (VIR)
:VIR
US Market

Vir Biotechnology (VIR) Balance Sheet

Compare
1,439 Followers

Vir Biotechnology Balance Sheet

Vir Biotechnology's total assets for Q3 2025 were $1.02B, a decrease of -14.51% from the previous quarter. VIR total liabilities were $223.35M for the fiscal quarter, a -8.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 1.40B$ 1.92B$ 2.80B$ 1.95B$ 918.76M
Total Liabilities
$ 248.43M$ 328.82M$ 724.13M$ 522.42M$ 201.91M
Total Equity Gross Minority
$ 1.15B$ 1.59B$ 2.08B$ 1.43B$ 716.85M
Other Metrics
Currency in USD

Vir Biotechnology Debt to Assets